SURVYR

RMD

ResMed|
$250.80
−$2.40 (0.95%)Oct 27 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-29%-18%-7%+4%+15%Oct 2025Oct 2026Apr 202652w high $273.7252w low $182.30
RMDSPY
Wall St. Highest PT $347.30 (+38.5%) Wall St. Avg PT $284.67 (+13.5%)
$182$226$270$314$358POC $251Hi $347Avg $285
Underwater Drawdown %Max DD -33.4%Current -8.4%
0.0%-33.4%
Relative Strength vs SPY-15.8% vs SPYUnderperforming
+46%0%-46%
1W
+$5.30 (2.16%)
1M
+$28.80 (12.97%)
3M
+$42.44 (20.37%)
6M
+$34.92 (16.18%)
YTD
+$11.88 (4.97%)
1Y
−$5.70 (2.22%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street & Morningstar coverage
Wall Street consensusNo covering analysts on file for RMD
Analyst price targetsNo target range on file
Morningstar star ratingNot rated
Checked Wall Street & Morningstar feeds · All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

52-week range$182.30 – $273.72

What they do

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air.

Healthcare · Medical Instruments & Supplies
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
23rd percentile in sector
D
12-1 return: -9.5%
Percentile within its GICS sector across the S&P 1500.
Growth
50th percentile in sector
C+
Revenue growth (YoY): +8.6%
Percentile within its GICS sector across the S&P 1500.
Value
49th percentile in sector
C+
Forward E/P: 5.5% · EBITDA/EV: 6.2%
Percentile within its GICS sector across the S&P 1500.
Profitability
85th percentile in sector
A-
Profit margin: +26.9% · Return on equity: +24.3%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 405 of 499 · 12-month momentum -11.4%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

RMD earningsNext report in 2 days
Next report · quarter Sep 2026
Thu Oct 29, 2026After the close
EPS consensus$2.67
Revenue consensus–
Last 4 quarters · EPS vs estimate
Aug 6, 2026$2.95est $2.89+2.0%Above estimates
Apr 30, 2026$2.86est $2.80+2.1%Above estimates
Jan 29, 2026$2.81est $2.72+3.1%Above estimates
Oct 30, 2025$2.55est $2.50+2.0%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-26 18:44:25 ET
24-1025-0125-0425-0725-1026-0126-0426-080.002.95
EstimateActual (beat)Actual (miss)

News & catalysts

More news
What Is the Required Minimum Distribution (RMD) for a $500,000 Retirement Account?
Nasdaq · 15h ago
IHI, MDT, RMD, BDX: Large Outflows Detected at ETF
Nasdaq · Oct 21
Insider trades
Rider Michael J
Global General Counsel · 2026-10-23
Sell
$102.0K
Farrell Michael J.
Director, Chairman and CEO · 2026-10-07
Sell
$1.1M
Farrell Michael J.
Director, Chairman and CEO · 2026-09-08
Sell
$1.1M
Farrell Peter C
Director · 2026-09-02
Sell
$227.7K
Farrell Michael J.
Director, Chairman and CEO · 2026-08-07
Sell
$1.0M
Farrell Peter C
Director · 2026-08-05
Sell
$1.8M
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-26 18:44:25 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026